South Africa faces another possible vaccine shortage ahead of AHS season

게시됨 2024년 7월 4일

Tridge 요약

South African horse owners are facing a shortage of African horse sickness (AHS) vaccines, causing concerns and leading to vaccine shortages and waiting lists. Onderstepoort Biological Products (OBP), the primary supplier, assures that vaccines for the current season will be available, with more expected in September 2024. Meanwhile, the direct export of registered horses from South Africa to Europe has been reinstated, adhering to EU legislation and AHS control measures. Despite the vaccine scarcity, South Africa has not experienced an epidemic of AHS-related deaths, and equestrian events are continuing as planned, with cancellations based on local outbreaks.
면책 조항: 위의 요약은 정보 제공 목적으로 Tridge 자체 학습 AI 모델에 의해 생성되었습니다.

원본 콘텐츠

South African horse owners are once again entering African horse sickness (AHS) season with a shortage of vaccines according to role players in the industry. Waiting lists at animal hospitals and equestrians unable to compete due to the lack of vaccines are slowly becoming the new norm as Onderstepoort Biological Products (OBP) struggles to meet the demand. OBP representatives say that they have been distributing the AHS vaccine for the past few weeks and are continuing to do so. They claim that the vaccines will be sufficient for this season and anticipate more availability in September 2024. However, Dr Evert Olivier, a veterinarian at Bapsfontein Animal Hospital, shares his concerns about the lack of vaccines provided by OBP: “Availability of the AHS and other vaccines from OBP is a big problem”. Olivier explains that their vaccine supply is low, and clients must be placed on a waiting list if they want vaccines for their horses. Read more about the confirmed Eastern Cape AHS ...
출처: Agriorbit

더 깊이 있는 인사이트가 필요하신가요?

귀사의 비즈니스에 맞춤화된 상세한 시장 분석 정보를 받아보세요.
'쿠키 허용'을 클릭하면 통계 및 개인 선호도 산출을 위한 쿠키 제공에 동의하게 됩니다. 개인정보 보호정책에서 쿠키에 대한 자세한 내용을 확인할 수 있습니다.